510(k) Special / Abbreviated

What it is

510(k) Special / Abbreviated are streamlined FDA premarket notification pathways to demonstrate substantial equivalence (SE) to a predicate when defined criteria are met. A Special 510(k) leverages design control verification and validation (V&V) for specific modifications to a manufacturer’s own cleared device; an Abbreviated 510(k) relies on FDA guidance, special controls, and recognized consensus standards to simplify content and review (FD&C Act §510(k); §513(i); 21 CFR 807 Subpart E; design controls per 21 CFR 820.30/QMSR).

Regulatory framework

• Statute & regs: FD&C Act §510(k), §513(i); 21 CFR 807 Subpart E (content, timing, SE decision).
• Special 510(k): For certain design/manufacturing changes to your own device; summarizes V&V performed under 21 CFR 820.30 using well-established methods, with no new questions of safety/effectiveness.
• Abbreviated 510(k): Anchored by FDA-recognized standards (21 USC 360d(c)), applicable special controls, and FDA guidance; include declarations of conformity (DoCs) and focused evidence to cover residual risks.
• Format & policy: eSTAR recommended; Refuse-to-Accept (RTA) policy applies; Additional Information (AI) requests may be issued during review.

Key elements / What it covers

• Intended use & indications: Must match the predicate; differences allowed only when they do not introduce new questions of safety/effectiveness.
• Technological characteristics: Compare materials, energy sources, algorithms, and performance; justify differences with risk-based V&V.
• Risk management: Map hazards to controls and acceptance criteria; align with ISO 14971 and device-specific standards/special controls.
• Standards & special controls: Provide DoCs and objective evidence (e.g., biocompatibility, electrical safety/EMC, software validation, sterilization/packaging, shelf life).

Process / How it works

• 1) Eligibility check: Confirm Special suitability (your own device; established methods; no new questions) or that Abbreviated is supported by current standards/special controls/guidance.
• 2) Evidence build: Execute risk-based V&V covering bench/analytical testing, biocompatibility, software (validation/cybersecurity), sterilization, packaging integrity, and shelf life as applicable.
• 3) Dossier compile: Prepare predicate comparison tables, method/result summaries, standards DoCs, labeling, and UDI basics; ensure product code/regulation alignment.
• 4) Submit via eSTAR: Satisfy RTA; respond to AI requests with clear cross-references and concise justifications.
• 5) Maintain records: Keep complete design-control documentation and traceability to support summarized claims in the submission.

Common pitfalls

• Using Special 510(k) when changes alter intended use or fundamental technology.
• Declaring standards conformity without test reports or clear traceability to acceptance criteria.
• Insufficient software documentation (SOUP control, cybersecurity posture, anomaly resolution).
• Weak biocompatibility or sterilization rationale when materials/processes change.
• Selecting a predicate that raises new questions of safety/effectiveness or is poorly matched.

Quick checks / Tips

• Do all differences close with V&V under design controls and raise no new questions?
• Do indications, users, and environment mirror the predicate language?
• Are standards DoCs complete and backed by objective evidence?
• Is labeling consistent with the SE comparison, risk mitigations, and intended use?